CHIBACHA

Chiral Base C−H Activation

 Coordinatore UNIVERSITAET BASEL 

 Organization address address: Petersplatz 1
city: BASEL
postcode: 4003

contact info
Titolo: Prof.
Nome: Olivier
Cognome: Baudoin
Email: send email
Telefono: +41 61 267 10 22

 Nazionalità Coordinatore Switzerland [CH]
 Totale costo 269˙743 €
 EC contributo 269˙743 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2013-IIF
 Funding Scheme MC-IIF
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-11-03   -   2016-11-02

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITAET BASEL

 Organization address address: Petersplatz 1
city: BASEL
postcode: 4003

contact info
Titolo: Prof.
Nome: Olivier
Cognome: Baudoin
Email: send email
Telefono: +41 61 267 10 22

CH (BASEL) coordinator 269˙743.80
2    UNIVERSITE LYON 1 CLAUDE BERNARD

 Organization address address: BOULEVARD DU 11 NOVEMBRE 1918 NUM43
city: VILLEURBANNE CEDEX
postcode: 69622

contact info
Titolo: Dr.
Nome: Javier
Cognome: Olaiz
Email: send email
Telefono: 33472697600
Fax: 33472697609

FR (VILLEURBANNE CEDEX) participant 0.00

Mappa

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

strategy    studied    chiral    addition    indanes    br    functionalized    liquids    ionic    reaction    oxidative    indolines    membered    first    sp    acids    minus    decarboxylation    asymmetric    cyclic    dihydrobenzofurans    induced    liquid    catalysis    reactions    cent    nsted    benzocyclobutenes    hetero    ligand    activation    base   

 Obiettivo del progetto (Objective)

'The goal of this proposal is to develop a new strategy for asymmetric C(sp3)−H activation using a chiral base instead of chiral ligand, and will focus on oxidative addition-induced and decarboxylation-induced reactions. Using this new strategy, a wide range of representative and valuable chiral four-membered (hetero)cyclic and five-membered (hetero)cyclic organic molecules will be synthesized. Typical chiral Br¢nsted acids and the designed ionic liquid-functionalized chiral phosphoric acids will be prepared by using commercially available raw materials. They will be tested in the two proposed concepts. In the case of oxidative addition-induced reactions, some feasible examples aiming at synthesizing chiral indanes, indolines, dihydrobenzofurans, benzocyclobutenes, and lactams will be developed from readily available aryl or alkenyl halides or triflates. For the decarboxylation-induced reactions, a racemic version will be first developed. Then, the chiral base concept will be applied in the synthesis of chiral benzocyclobutenes, indanes, indolines, and dihydrobenzofurans. In each of the reactions involved, some key reaction parameters including chiral acid, ligand, solvent, base, reaction temperature as well as the structural features of the substrates will be studied. In addition, recyclable ionic liquid-functionalized chiral Br¢nsted acids and the effect of traditional ionic liquids as the additives or solvents will be first studied in enantioselective C(sp3)−H bond activation. In order to get a clear understanding on the nature of the asymmetric induction during the catalytic cycle, computational studies will also be performed using DFT methods. The applicant's previous research experience in C−H activation, ionic liquids catalysis and asymmetric catalysis areas will benefit the project. The project will foster mutually beneficial research collaboration in Europe in the field of C−H activation and green chemistry.'

Altri progetti dello stesso programma (FP7-PEOPLE)

NARILAR (2011)

New Working Fluids based on Natural Refrigerants and Ionic Liquids for Absorption Refrigeration

Read More  

INTERACT (2015)

Interactions in Community Treatment

Read More  

STEM CELL IMAGING (2011)

Molecular imaging of the myocardium to facilitate cardiac stem cell therapy

Read More